Impact of percutaneous coronary intervention timing on 5-year outcome in patients with non-ST-segment elevation acute coronary syndromes. The ‘wait a day’ approach might be safer

BACKGROUND: The OPTIMA trial was a randomised multicentre trial exploring the influence of the timing of percutaneous coronary intervention (PCI) on patient outcomes in an intermediate to high risk non-ST-elevation acute coronary syndrome (NSTE-ACS) population. In order to decide the best treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Oosterwerff, Erik F.J., Fagel, N. D., Slagboom, T., Tijssen, J. G. P., Herrman, J. P., Smits, P. C., Suttorp, M. J., Ronner, E., Laarman, G. J., Patterson, M. S., Amoroso, G., Vink, M. A., van der Schaaf, R. J., Verheugt, F. W. A., Riezebos, R. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2016
Materias:
Original Article - E-learning Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771630/
https://www.ncbi.nlm.nih.gov/pubmed/26860709
http://dx.doi.org/10.1007/s12471-016-0803-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771630/
https://www.ncbi.nlm.nih.gov/pubmed/26860709
http://dx.doi.org/10.1007/s12471-016-0803-0

Ejemplares similares